Century Therapeutics: CNTY-813 IND Submission On Track for Q4 2026

Century Therapeutics Inc. reported new nonclinical data for CNTY-813. The company stated that its IND submission remains on track for the fourth quarter of 2026, with initial clinical data anticipated in the second half of 2027.